The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agent
- 1 September 1980
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 19 (9), 831-837
- https://doi.org/10.1016/0028-3908(80)90079-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Bromocriptine‐induced behavioral hypersensitivityNeurology, 1978
- Bromocriptine in ParkinsonismArchives of Neurology, 1978
- Considerations in the management of parkinsonismNeurology, 1978
- Levodopa‐Induced dopamine receptor hypersensitivityAnnals of Neurology, 1977
- STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 1976
- Amphetamine-Induced Dopaminergic Hypersensitivity in Guinea PigsArchives of General Psychiatry, 1975
- Studies on the antiparkinsonian efficacy of lergotrileNeurology, 1975
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Behavioural Stereotypies Induced by Pharmacological AgentsPharmacopsychiatry, 1968
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967